Literature DB >> 19815012

The effects of parkin suppression on the behaviour, amyloid processing, and cell survival in APP mutant transgenic mice.

Juan Perucho1, Maria J Casarejos, Isabel Rubio, José A Rodriguez-Navarro, Ana Gómez, Israel Ampuero, Izaskun Rodal, Rosa M Solano, Eva Carro, Justo García de Yébenes, Maria A Mena.   

Abstract

Parkin suppression induces accumulation of beta-amyloid in mutant tau mice. We studied the effect of parkin suppression on behaviour and brain pathology in APP(swe) mutant mice. We produced double mutant mice with human mutated APP(swe)+partial (hemizygote) or total (homozygote) deletion of Park-2 gene. We studied the development, behaviour, brain histology, and biochemistry of 12- and 16-month-old animals in 6 groups of mice, with identical genetic background: wild-type (WT), APP(swe) overexpressing (APP), hemizygote and homozygote deletion of Park-2 (PK(+/-) and PK(-/-), respectively), and double mutants (APP/PK(+/-) and APP/PK(-/-)). APP mice have reduced weight gain, decreased motor activity, and reduced number of entrances and of arm alternation in the Y-maze, abnormalities which were partially or completely normalized in APP/PK(+/-) and APP/PK(-/-) mice. The double mutants had similar number of mutant human APP transgene copies than the APP and levels of 40 and 80 kDa proteins; but both of them, APP/PK(+/-) and APP/PK(-/-) mice, had less plaques in cortex and hippocampus than the APP mice. APP mutant mice had increased apoptosis, proapoptotic Bax/Bcl2 ratios, and gliosis, but these death-promoting factors were normalized in APP/PK(+/-) and APP/PK(-/-) mice. APP mutant mice had an increased number of tau immunoreactive neuritic plaques in the cerebral cortex as well as increased levels of total and phosphorylated tau protein, and these changes were partially normalized in APP/PK(+/-) heterozygotic and homozygotic APP/PK(-/-) mice. Compensatory protein-degrading systems such as HSP70, CHIP, and macroautophagy were increased in APP/PK(+/-) and APP/PK(-/-). Furthermore, the chymotrypsin- and trypsin-like proteasome activities, decreased in APP mice in comparison with WT, were normalized in the APP/PK(-/-) mice. We proposed that partial and total suppression of parkin triggers compensatory mechanisms, such as chaperone overexpression and increased autophagy, which improved the behavioural and cellular phenotype of APP(swe) mice.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19815012     DOI: 10.1016/j.expneurol.2009.09.029

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  8 in total

Review 1.  Neurologic and motor dysfunctions in APP transgenic mice.

Authors:  Robert Lalonde; Ken-Ichiro Fukuchi; Catherine Strazielle
Journal:  Rev Neurosci       Date:  2012       Impact factor: 4.353

2.  Nilotinib-induced autophagic changes increase endogenous parkin level and ubiquitination, leading to amyloid clearance.

Authors:  Irina Lonskaya; Michaeline L Hebron; Nicole M Desforges; Joel B Schachter; Charbel E-H Moussa
Journal:  J Mol Med (Berl)       Date:  2013-12-13       Impact factor: 4.599

3.  The Relationship between Parkin and Protein Aggregation in Neurodegenerative Diseases.

Authors:  Preeti J Khandelwal; Charbel E-H Moussa
Journal:  Front Psychiatry       Date:  2010-06-03       Impact factor: 4.157

4.  Behavioral and neurotransmitter abnormalities in mice deficient for Parkin, DJ-1 and superoxide dismutase.

Authors:  Meghan R Hennis; Katherine W Seamans; Marian A Marvin; Bradford H Casey; Matthew S Goldberg
Journal:  PLoS One       Date:  2013-12-26       Impact factor: 3.240

5.  Lipidomic Alterations in the Mitochondria of Aged Parkin Null Mice Relevant to Autophagy.

Authors:  Angel Gaudioso; Patricia Garcia-Rozas; Maria Jose Casarejos; Oscar Pastor; Jose Antonio Rodriguez-Navarro
Journal:  Front Neurosci       Date:  2019-04-24       Impact factor: 4.677

6.  Liver Growth Factor "LGF" as a Therapeutic Agent for Alzheimer's Disease.

Authors:  Rafael Gonzalo-Gobernado; Juan Perucho; Manuela Vallejo-Muñoz; Maria José Casarejos; Diana Reimers; Adriano Jiménez-Escrig; Ana Gómez; Gonzalo M Ulzurrun de Asanza; Eulalia Bazán
Journal:  Int J Mol Sci       Date:  2020-12-02       Impact factor: 5.923

7.  Tyrosine kinase inhibition increases functional parkin-Beclin-1 interaction and enhances amyloid clearance and cognitive performance.

Authors:  Irina Lonskaya; Michaeline L Hebron; Nicole M Desforges; Alexander Franjie; Charbel E-H Moussa
Journal:  EMBO Mol Med       Date:  2013-07-04       Impact factor: 12.137

8.  Krüppel-like factor 6 rendered rat Schwann cell more sensitive to apoptosis via upregulating FAS expression.

Authors:  Ting Gui; Yueming Wang; Lixing Zhang; Wenjing Wang; Hao Zhu; Wenlong Ding
Journal:  PLoS One       Date:  2013-12-04       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.